Not applicableStudy completedNCT04072731
What this trial is testing
SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer
Who this might be right for
Thyroid Cancer
People's Hospital of Zhengzhou University 140
Showing 20 of 575 results